BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Elloumi H, Houissa F, Hadj NB, Gargouri D, Romani M, Kharrat J, Ghorbel A. Sudden hearing loss associated with peginterferon and ribavirin combination therapy during hepatitis C treatment. World J Gastroenterol 2007; 13(40): 5411-5412 [PMID: 17879419 DOI: 10.3748/wjg.v13.i40.5411]
URL: https://www.wjgnet.com/1007-9327/full/v13/i40/5411.htm
Number Citing Articles
1
Debasis Das, Jian Hong, Shu-Hui Chen, Guangyi Wang, Leonid Beigelman, Scott D. Seiwert, Brad O. Buckman. Recent advances in drug discovery of benzothiadiazine and related analogs as HCV NS5B polymerase inhibitorsBioorganic & Medicinal Chemistry 2011; 19(16): 4690 doi: 10.1016/j.bmc.2011.06.079
2
Christine Little, Maura K. Cosetti. A Narrative Review of Pharmacologic Treatments for COVID ‐19: Safety Considerations and Ototoxicity The Laryngoscope 2021; 131(7): 1626 doi: 10.1002/lary.29424
3
Current awareness: Pharmacoepidemiology and drug safetyPharmacoepidemiology and Drug Safety 2008; 17(5): i doi: 10.1002/pds.1486
4
Samir Asal, Ossama Sobhy, Omneya Ismail, Essam Bedewy. Study of the effect of combined interferon and ribavirin therapy on the hearing profile of hepatitis C virus patientsThe Egyptian Journal of Otolaryngology 2015; 31(4): 237 doi: 10.4103/1012-5574.168359
5
Vu Le, Ted Bader, Javid Fazili. A case of hearing loss associated with pegylated interferon and ribavirin treatment ameliorated by prednisoneNature Clinical Practice Gastroenterology & Hepatology 2009; 6(1): 57 doi: 10.1038/ncpgasthep1317
6
Gulden Eser Karlidag, Turgut Karlidag, Kutbettin Demirdag, Erol Keles. The effects of pegylated interferon/lamivudine therapy on auditory functions in patients with chronic hepatitis BAuris Nasus Larynx 2011; 38(3): 312 doi: 10.1016/j.anl.2010.10.007
7
Lisa Evans DeWald, Chloe Starr, Terry Butters, Anthony Treston, Kelly L. Warfield. Iminosugars: A host-targeted approach to combat Flaviviridae infectionsAntiviral Research 2020; 184: 104881 doi: 10.1016/j.antiviral.2020.104881
8
Takuya Kitada, Takashi Narimatsu, Seiko Yamaguchi. Sudden hearing loss in a patient with chronic hepatitis C treated with pegylated interferon α2a and ribavirinKanzo 2009; 50(7): 371 doi: 10.2957/kanzo.50.371
9
Mizuki Tanaka, Shiori Hasegawa, Satoshi Nakao, Kazuyo Shimada, Ririka Mukai, Kiyoka Matsumoto, Mitsuhiro Nakamura, Jinn-Moon Yang. Analysis of drug-induced hearing loss by using a spontaneous reporting system databasePLOS ONE 2019; 14(10): e0217951 doi: 10.1371/journal.pone.0217951
10
Min Ki Shin, Tae Hyo Kim, Kang Ju, Chang Yoon Ha, Hyun Ju Min, Woon Tae Jung, Ok Jae Lee. A case of sudden-onset hearing loss in a patient treated with peginterferon α-2b and ribavirin for chronic hepatitis CThe Korean Journal of Hepatology 2009; 15(3): 370 doi: 10.3350/kjhep.2009.15.3.370
11
Mohammad Reza Sharifian, Shima Kamandi, Hamid Reza Sima, Mohammad Ali Zaringhalam, Mehdi Bakhshaee. INF-αand OtotoxicityBioMed Research International 2013; 2013: 1 doi: 10.1155/2013/295327
12
Debasis Das. Viral Proteases and Their Inhibitors2017; : 189 doi: 10.1016/B978-0-12-809712-0.00008-3